SCHEMBL4913073

SCHEMBL4913073

c1ccc(-c2cc(-c3ccc(-c4ccccn4)cc3)c(-c3ccccc3)c(-c3ccccc3)c2-c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.46
CYP2A6 P11509 1/20 0.46
LMNA P02545 3/20 0.45
CYP1A2 P05177 2/20 0.45
CCR1 P32246 2/20 0.45
CCR5 P51681 2/20 0.45
CCR8 P51685 2/20 0.45
KDM4E B2RXH2 2/20 0.45
POLB P06746 1/20 0.45
METAP1 P53582 1/20 0.45
BLM P54132 1/20 0.45
HIF1A Q16665 1/20 0.45
DOHH Q9BU89 1/20 0.45
P4HTM Q9NXG6 1/20 0.45
KDR P35968 1/20 0.44
TOP1 P11387 2/20 0.44
DHODH Q02127 1/20 0.43
MAPT P10636 2/20 0.43
RAB9A P51151 2/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22956076 0.94 DHODH (0.46) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL4124154 0.91 TGFBR1 (0.47) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL3892684 0.90 TGFBR1 (0.44) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL9974907 0.89 LMNA (0.52) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL22956100 0.88 TGFBR1 (0.43) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL22956079 0.88 DHODH (0.42) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL9974919 0.87 LMNA (0.50) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL22956108 0.87 TGFBR1 (0.42) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL28899126 0.86 TGFBR1 (0.44) TGFBR1CYP2A6LMNACYP1A2CCR1
SCHEMBL22956077 0.86 KDR (0.41) TGFBR1CYP2A6LMNACYP1A2CCR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9078330-B2 Highly branched dendrimers ISIS INNOVATION LIMITED (GB) 2015-07-07 US disclosed
US-20080211391-A1 Highly Branched Dendrimers CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2008-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080211391-A1 Highly Branched Dendrimers ITGB1, PICALM, BTN3A1 TGFBR1 487/4885CYP2A6 4510/4885LMNA 977/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.